Month: November 2024

.China’s Duality Biotherapeutics has actually filed (PDF) paperwork for a Hong Kong IPO, seeking an undisclosed amount to power a vast pipe of antibody-drug conjugates

.Though Alkeus Pharmaceuticals’ oral eye illness resource failed to significantly minimize geographic degeneration (GA) lesion development, the biotech is actually mentioning “medically meaningful” outcomes as

.While the biotech investment scene in Europe has reduced quite following a COVID-19 financing boom in 2021, a brand new document from PitchBook suggests venture

.Merck &amp Co. has quickly redeemed a number of the costs of its Weapon Therapeutics acquistion, drawing in $170 million beforehand by integrating the lead

.Cullinan Rehab was actually excited good enough along with Port BioMed’s bispecific invulnerable activator that it entrusted $25 thousand in 2013 for the medicine’s united

.Accept to today’s Chutes &amp Ladders, our roundup of substantial leadership hirings, firings and also retirings throughout the market. Please send the recommendation– or the

.Compass Pathways’ trip to phase 3 psychedelic clinical depression information is taking longer than counted on. With the tests overwhelming through months, the biotech is

.Vertex has stated stage 3 information on its near-approval ache drug applicant suzetrigine, clarifying just how the non-opioid painkiller integrates with advil and why the

.Cognition Therapeutics’ phase 2 SHINE trial has taken a few of the radiance off the Alzheimer’s disease medicine candidate CT1812. The dental sigma-2 villain neglected

.Invite to this week’s Chutes &amp Ladders, our summary of substantial management hirings, shootings and retirings throughout the field. Satisfy send out the recommendation– or